[1]向 红,孙香娟,常 克,等.调运枢纽推拿术联合重组人生长激素对矮小症患儿生长发育的影响*[J].陕西中医,2020,(6):766-769.[doi:DOI:10.3969/j.issn.10007369.2020.06.018]
　XIANG Hong,SUN Xiangjuan,CHANG Ke,et al.Influence of Tiaoyun Shuniu massage and recombinant human growth hormone on growth and development of dwarf children[J].,2020,(6):766-769.[doi:DOI:10.3969/j.issn.10007369.2020.06.018]
点击复制

调运枢纽推拿术联合重组人生长激素对矮小症患儿生长发育的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年6期
页码:
766-769
栏目:
临床研究
出版日期:
2020-06-01

文章信息/Info

Title:
Influence of Tiaoyun Shuniu massage and recombinant human growth hormone on growth and development of dwarf children
作者:
向 红; 孙香娟; 常 克; 王海俊; 张 芹; 彭 玉; 汪 雅△
成都中医药大学附属医院儿科(成都 610075)
Author(s):
XIANG Hong; SUN Xiangjuan; CHANG Ke; et al.
Department of Pediatrics,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine(Chengdu 610075)
关键词:
矮小症;  调运枢纽;  经络腧穴;  推拿术;  重组人生长激素;  生长发育
Keywords:
Dwarfism;  Tiaoyun Shuniu;  Meridian points;  Massage;  Recombinant human growth hormone;  Growth and development
分类号:
R272.6
DOI:
DOI:10.3969/j.issn.10007369.2020.06.018
文献标志码:
A
摘要:
目的:探讨基于经络腧穴理论的“调运枢纽”推拿术联合重组人生长激素治疗对矮小症患儿的生长发育影响的研究。方法:160例矮小症患儿作为研究对象,随机分为观察组80例和对照组80例。对照组采用药物治疗,观察组接受基于经络腧穴理论的“调运枢纽”推拿术治疗。比较治疗后生长指标及甲状腺功能,检测并比较血清胰岛素样生长因子(IGF-1)、血清胰岛素样生长因子结合蛋白-3(IGFBP-3)水平,观察不良反应发生情况。结果:与对照组比,观察组患儿体重明显增加,身高增加差异具有统计学意义(P<0.05)。治疗后两组患儿身高标准差及生长速率均有增高,观察组3个月后较对照组身高SDS改变明显,生长速率显著增加,差异具有统计学意义(P<0.05)。治疗3个月后血清IGF-1均有增加,观察组患儿血清IGF-1、IGFBP-3水平高于对照组,但差异无统计学意义(P>0.05)。两组患者不良反应发生情况比较,差异无统计学意义(P>0.05)。观察组仅一例患儿出现轻微眼睑浮肿,1周后自行消失。结论:基于经络腧穴理论的“调运枢纽”推拿术联合药物治疗矮小症患儿临床效果较好。
Abstract:
Objective:To investigate the effect of Tiaoyun Shuniu massage therapy combined with recombinant human growth hormone on the growth and development of dwarf children based on the theory of meridian acupoints.Methods:160 cases of dwarf children in our hospital were selected as the research objects,and they were divided into observation group 80 cases and control group 80 cases according to random number table method.The control group was treated with a single drug,and the observation group received Tiaoyun Shuniu massage therapy based on the theory of meridian and acupoints.The growth indicators and thyroid function were compared after treatment,and serum-like growth factor-1(IGF-1)and serum insulin-like growth factor binding protein-3(IGFBP-3)level,observe the occurrence of adverse reactions.Results:Compared with the control group,the children in the observation group increased significantly in weight,and the increase in height was statistically significant(P<0.05).After treatment,the standard deviation and growth rate of the children in the two groups were increased.The observation group had a significantly higher SDS change in height and significantly increased growth rate after 3 months.The difference was statistically significant(P<0.05).Serum IGF-1 increased,and the levels of serum IGF-1 and IGFBP-3 in the observation group were higher than those in the control group,but the difference was not statistically significant(P>0.05).There was no significant difference in the incidence of adverse reactions between the two groups of patients(P>0.05).Only one child in the observation group developed slight eyelid edema,which disappeared after 1 week.Conclusion:Tiaoyun Shuniu massage based on the theory of meridian and acupoints has significant clinical effect in treating dwarf children.

参考文献/References:

[1] Carolina AE,Carla BM,Aguayo AM,et al.Adult height of children with idiopathic short stature treated with growth hormone therapy[J].Revista Chilena De Pediatria,2016,87(1):37-40.
[2] 吴 韬,杜俊文,张 坤,等.儿童矮小症485例病因探讨及治疗效果[J].河北医科大学学报,2018,39(12):1384-1388.
[3] 王秀利,武 娇,杨丹艳,等.不同剂量重组人生长激素治疗特发性矮小症的疗效观察[J].医药前沿,2016,6(29):155-157.
[4] Choi SH,Fan D,Hwang MS,et al.Effect of growth hormone treatment on craniofacial growth in children:idiopathic short stature versus growth hormone deficiency[J].J Form Med Ass,2016,116(4):236-238.
[5] Grimberg A,Allen DB.Growth hormone treatment for growth hormone deficiency and idiopathic short stature:new guidelines shaped by the presence and absence of evidence[J].Current Opin Pediat,2017,29(4):466-468.
[6] Pasquino AM,Albanese A,Bozzola M,et al.Idiopathic short stature[J].Endocrinol Metab Clin North Am,2016,14(3):565-580.
[7] Mauras N,Ross JL,Gagliardi P,et al.Randomized trial of aromatase inhibitors,growth hormone,or combination in pubertal boys with idiopathic,short stature[J].J Clin Endocrinol Metab,2016,101(12):123-125.
[8] Rothenbuhler A,Esterle L,Gueorguieva I,et al.Two-year recombinant human growth hormone(rhGH)treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets(XLHR)[J].Growth Horm IGF Res,2017,36(8):11-15.
[9] 侯玉婷,王艳辉,张绍彩,等.基于经络腧穴理论的“调运枢纽”推拿术对厌食症 患儿的临床疗效及生长发育的影响[J].河北医学,2019,25(5):875-878.
[10] 中华医学会儿科学分会内分泌遗传代谢学组.矮身材儿童诊治指南[J].中华儿科杂志,2008,46(6):20-21.
[11] 中华医学会儿科学分会内分泌遗传代谢学组,《中华儿科杂志》编辑委员会,梁 雁.基因重组人生长激素儿科临床规范应用的建议[J].中华儿科杂志,2013,51(6):426-432.
[12] Klar Z,Kocaay P,Amtosun E,et al.The effect of recom-binant growth hormone treatment in children with idio-pathic short stature and low insulin-like growth factor-1levels[J].J Clin Res Pediatr Endocrinol,2015,7(4):301-306.
[13] 任 翼,陈 江,谭志团,等.重组人生长激素治疗特发性矮小症和生长激素缺乏症的比较[J].广东医学,2016,37(19):2961-2963.
[14] Schnabel D,Partsch CJ,Huang M,et al.Acceptance of a reusable self-injection device for recombinant human groeth hormone:final data from a questionnaire-based,cross-sectional,internatinal,multicenter,observational study in pediatric patients[J].Medicine,2016,9(15):317-324.
[15] 刘功莲,吴建跃.重组人生长激素在矮小症替代疗法中的不良反应[J].贵州医药,2016,40(2):220-222.
[16] 谢剑锋,邱述建,肖高小.重组人生长激素治疗儿童矮小症的效果对比研究[J].中国医药创新,2019,16(15):55-59.
[17] 田 慧,曾远辉.中西医结合治疗特发性矮小症近期疗效分析[J].中医儿科杂志,2017,15(6):39-43.
[18] 陈 倩,杨 亭,张 萱,等.生长激素治疗儿童特发性矮小症疗效分析[J].儿科药学杂志,2019,17(6):6-9.
[19] 王 荣,贾爱华,刘新艳, 等.IGF-1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,48(9):1163-1166.
[20] 杨宏芳,林小晶,王晓慧.4周有氧运动与饮食控制对肥胖女青少年血清IGF-1和IGF-1结合蛋白-3水平的影响[J].中国应用生理学杂志,2018,34(1):78-82.
[21] 康军朋,郭淑芹,张云良, 等.结直肠癌组织中IGF-1R、IGFBP-3的表达及意义[J].临床与实验病理学杂志,2014,30(2):149-152.
[22] 侯文婧,徐小薇,潘 慧.中国北方汉族健康受试者IGFBP-3基因启动子-202位点基因型的测定与分析[J].中国卫生检验杂志,2010,20(6):1297-1298,1310.

备注/Memo

备注/Memo:
*四川省科技计划项目(2018JY0660)
更新日期/Last Update: 2020-06-09